BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9200337)

  • 1. Tissue factor and plasminogen activator inhibitor type 2 expression in human stimulated monocytes is inhibited by heparin.
    Pepe G; Giusti B; Attanasio M; Gori AM; Comeglio P; Martini F; Gensini G; Abbate R; Neri Serneri GG
    Semin Thromb Hemost; 1997; 23(2):135-41. PubMed ID: 9200337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ochratoxin A inhibits the production of tissue factor and plasminogen activator inhibitor-2 by human blood mononuclear cells: another potential mechanism of immune-suppression.
    Rossiello MR; Rotunno C; Coluccia A; Carratù MR; Di Santo A; Evangelista V; Semeraro N; Colucci M
    Toxicol Appl Pharmacol; 2008 Jun; 229(2):227-31. PubMed ID: 18289624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
    Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
    Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein tyrosine kinase activation is required for LPS and PMA induction of tissue factor mRNA in human blood monocytes.
    Ternisien C; Ollivier V; Khechai F; Ramani M; Hakim J; de Prost D
    Thromb Haemost; 1995 Mar; 73(3):413-20. PubMed ID: 7545319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine gene expression in human LPS- and IFNgamma-stimulated mononuclear cells is inhibited by heparin.
    Attanasio M; Gori AM; Giusti B; Pepe G; Comeglio P; Brunelli T; Prisco D; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1998 May; 79(5):959-62. PubMed ID: 9609229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin inhibits tissue factor and plasminogen activator inhibitor-1 secretion by peripheral blood mononuclear cells in patients with primary nephrotic syndrome.
    Wei JL; Cui HM; Ma CY
    Eur J Med Res; 2007 May; 12(5):216-21. PubMed ID: 17513194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potentially effective antisense oligodeoxyribonucleotide (ODN) sequences for inhibiting plasminogen activator inhibitor-2 (PAI-2) production by monocytes.
    Humphries J; Burnand KG; Cunningham P; Brock A; Westwood N; Smith A
    Thromb Haemost; 2002 Jul; 88(1):131-6. PubMed ID: 12152653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes.
    He M; He X; Xie Q; Chen F; He S
    Thromb Res; 2006; 117(5):579-90. PubMed ID: 15953627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
    Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
    Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cells.
    Montemurro P; Barbuti G; Dundon WG; Del Giudice G; Rappuoli R; Colucci M; De Rinaldis P; Montecucco C; Semeraro N; Papini E
    J Infect Dis; 2001 Apr; 183(7):1055-62. PubMed ID: 11237830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
    Gross TJ; Sitrin RG
    J Immunol; 1990 Mar; 144(5):1873-9. PubMed ID: 2307845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 mRNA expression in cultured pigmented ciliary epithelial cells of the porcine eye.
    Meyer MW; von Depka M; Wilhelm C; Schröder A; Erb C
    Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):679-86. PubMed ID: 12192463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of heparin and related sulfated polysaccharides on tissue factor expression induced by mitogenic and non-mitogenic factors in human vascular smooth muscle cells.
    Xuereb JM; Herbert JM; Sie P; Boneu B; Constans J
    Thromb Haemost; 1999 Jan; 81(1):151-6. PubMed ID: 10348708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide.
    Pradier O; Gérard C; Delvaux A; Lybin M; Abramowicz D; Capel P; Velu T; Goldman M
    Eur J Immunol; 1993 Oct; 23(10):2700-3. PubMed ID: 8405069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human peripheral blood endothelial progenitor cells synthesize and express functionally active tissue factor.
    Di Stefano R; Barsotti MC; Armani C; Santoni T; Lorenzet R; Balbarini A; Celi A
    Thromb Res; 2009 Apr; 123(6):925-30. PubMed ID: 19128821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased mononuclear cell tissue factor and type-2 plasminogen activator inhibitor and reduced plasma fibrinolytic capacity in children with lymphoma.
    Semeraro N; Montemurro P; Giordano P; Santoro N; De Mattia D; Colucci M
    Thromb Haemost; 1994 Jul; 72(1):54-7. PubMed ID: 7974375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenofibrate inhibits thrombogenic and fibrinolytic factors expression in adipose tissue of atherosclerotic rabbits.
    Zhao SP; Li J; Xu Z; Wu J; Li Q; Ye H
    Clin Chim Acta; 2004 Nov; 349(1-2):81-6. PubMed ID: 15469859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone enhances LPS induction of tissue factor expression in human monocytic cells by increasing tissue factor mRNA stability.
    Reddy KV; Bhattacharjee G; Schabbauer G; Hollis A; Kempf K; Tencati M; O'Connell M; Guha M; Mackman N
    J Leukoc Biol; 2004 Jul; 76(1):145-51. PubMed ID: 15075360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anisodamine counteracts lipopolysaccharide-induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells: contribution of the NF-kappa b pathway.
    Ruan QR; Zhang WJ; Hufnagl P; Kaun C; Binder BR; Wojta J
    J Vasc Res; 2001; 38(1):13-9. PubMed ID: 11173990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.